Stockreport

Lexeo Therapeutics GAAP EPS of -$0.27 beats by $0.04 [Seeking Alpha]

Lexeo Therapeutics, Inc.  (LXEO) 
PDF As of December 31, 2025, cash, cash equivalents, and investments in marketable securities were $246.6 million, which Lexeo believes will be sufficient to fund operation [Read more]